To explore the relationship between the type of clinician (generalist vs subspecialist) initially seen by infertile women, the treatment received, and the time to pregnancy.
Methods
We analyzed mixed-mode questionnaire data from 867 women with primary infertility enrolled into a retrospective cohort through population- and fertility clinic-based sampling. We compared women presenting first to generalist providers with women presenting first to fertility subspecialists, with the main outcomes of receiving in vitro fertilization (IVF), time to pregnancy, and live birth.
Results
The first contact for most (84%) women with infertility was a generalist provider. Only 8% of women sought care first from a fertility subspecialist, and these women were older and had been trying longer to conceive. Women who presented first to a generalist provider were less likely to receive IVF (adjusted odds ratio, 0.48; 95% confidence interval, 0.28-0.82), were equally likely to achieve pregnancy, and had similar times to pregnancy (adjusted hazard ratio, 1.11; 95% confidence interval, 0.80-1.53) compared with women who presented first to a subspecialist.
Conclusions
Generalist providers are frequently the first point of care for women with difficulty conceiving and are uniquely positioned to promote the balanced management of infertility.
fertility treatment provider type outcomes, generalist vs subspecialist infertility care, IVF utilization primary care referral, time to pregnancy clinician type, infertility treatment pathways, reproductive endocrinologist referral patterns, family medicine fertility care, fertility subspecialist access, infertility treatment disparities provider, initial fertility consultation outcomes
PMID 28379830 28379830 DOI 10.3122/jabfm.2017.02.160184 10.3122/jabfm.2017.02.160184
Cite this article
Boltz, M. W., Sanders, J. N., Simonsen, S. E., & Stanford, J. B. (2017). Fertility Treatment, Use of in Vitro Fertilization, and Time to Live Birth Based on Initial Provider Type. *Journal of the American Board of Family Medicine : JABFM*, *30*(2), 230-238. https://doi.org/10.3122/jabfm.2017.02.160184
Boltz MW, Sanders JN, Simonsen SE, Stanford JB. Fertility Treatment, Use of in Vitro Fertilization, and Time to Live Birth Based on Initial Provider Type. J Am Board Fam Med. 2017;30(2):230-238. doi:10.3122/jabfm.2017.02.160184
Boltz, M. W., et al. "Fertility Treatment, Use of in Vitro Fertilization, and Time to Live Birth Based on Initial Provider Type." *Journal of the American Board of Family Medicine : JABFM*, vol. 30, no. 2, 2017, pp. 230-238.
Keywords
Adult, Female, Fertilization in Vitro/statistics & Numerical Data, General Practitioners, Humans, Infertility, Female/therapy, Live Birth, Odds Ratio, Pregnancy, Retrospective Studies, Surveys and Questionnaires, Time-to-Pregnancy, Treatment Outcome, Female; Live Birth; Point-of-Care Systems; Pregnancy; Retrospective Studies; Surveys and Questionnaires; Time-to-Pregnancy, Fertilization; Fertilization in Vitro; Infertility
Serum progesterone (P) levels are critical for endometrial receptivity and implantation in frozen-thawed embryo transfer (FET) cycles. However, the prognostic role of P levels measured on the day of t...
BACKGROUND: Social Egg Freezing (SEF), often promoted in Western contexts as a means to enhance reproductive autonomy, has seen varied uptake in countries with wider gender disparities. In such settin...
STUDY QUESTION: Is there a difference in live birth rates at 24 months between infertile women with polycystic ovary syndrome (PCOS) who have normal versus abnormal glucose metabolism?
SUMMARY ANSWER...
PURPOSE: To evaluate the clinical relevance of serum progesterone levels on the day of frozen embryo transfer (FET) and the dose of vaginal progesterone gel (Crinone) used for early luteal phase suppo...